RNA, widely known from the COVID-19 vaccine, is not actually a "therapeutic agent," but a technology that delivers the ...
Sara Moniuszko is a health and lifestyle reporter at CBSNews.com. Previously, she wrote for USA Today, where she was selected to help launch the newspaper's wellness vertical. She now covers breaking ...
Nobel Prize-winning mRNA technology, which saved millions of lives during the COVID-19 pandemic through vaccines, is now being redirected toward fighting cancer, cystic fibrosis, and other serious ...
WASHINGTON (AP) — So-called mRNA vaccines saved millions of lives during the COVID-19 pandemic — and now scientists are using that Nobel Prize-winning technology to try to develop vaccines and ...
SAN ANTONIO – The federal government’s decision to slash $500 million in funding for mRNA vaccine research has sparked concern among health experts. “The news that we’re going to block a Nobel ...
Ongoing federal support for mRNA technology and research could make good on a longstanding presidential promise to cure cancer, according to Jeff Coller, Bloomberg Distinguished Professor of RNA ...
Health and Human Services Secretary Robert F. Kennedy Jr. announced this week that HHS is terminating about $500 million in investments in developing mRNA vaccines. The technology instructs the body ...
Share on Pinterest RFK Jr.’s decision to pull funding for mRNA vaccines could thwart public health responses to future pandemics. Anna Moneymaker/Getty Images HHS Secretary Robert F. Kennedy Jr.
The Trump administration is terminating 22 contracts focused on developing mRNA vaccines and winding down additional federal investments in mRNA technology, Health and Human Services Secretary Robert ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results